Insider Activity of Ignelzi Troy A.
According to the SEC Form 4 filings, Ignelzi Troy A., being in a position of
- Chief Financial Officer at Rapport Therapeutics, Inc. Common Stock,оver the last 12 months, has bought 5500 shares for $143,550, and sold 0 shares,over all time since 2025-03-12, has bought 15500 shares for $244,538, and sold 0 shares.
Biography of Ignelzi Troy A.
No biography is available at this moment.